Evan Valenti

Evan Valenti is the founder of Purest Peptide, a US-sourced research peptide company built around lab-tested purity, transparent sourcing, and price discipline.

Evan spent years inside the high-risk payments world, working with merchants the rest of the industry refused to underwrite. Peptide companies were everywhere on that desk. He watched processor after processor freeze accounts, hold reserves, and reverse settlements over sourcing questions and product claims. The pattern was always the same: the products were fine, the paperwork was not.

He is also a peptide user himself. As scrutiny on China-sourced raw material intensified through 2024 and 2025 and federal regulators sharpened their stance on grey-market labs, the gap between what serious researchers needed and what the market offered widened quickly.

Purest Peptide is the response. Every compound is synthesized in the United States, every batch ships with a third-party Certificate of Analysis, and pricing is benchmarked against the best international labs so cost is never the reason researchers compromise on purity.